IDiyas

For the Inventor, By the Inventor

Suita, Japan

Yasuhiko Kawano

USPTO Granted Patents = 14

Average Co-Inventor Count = 3.2

ph-index = 6

Forward Citations = 87(Granted Patents)


Location History:

  • Osaka, JA (1976)
  • Nishinomiya, JP (1978 - 1979)
  • Suita, JP (1980 - 2005)

Company Filing History:

goldMedal14 out of 1,858 
 
Takeda Chemical Industries, Inc.
 patents

Years Active: 1976-2005

Loading Chart...
14 patents (USPTO):Explore Patents
1. 6924292 - Furoisoquinoline derivatives, process for producing the same and use thereof (2005-08-02),
2. 6627630 - Condensed pyridazine derivatives, their production and use (2003-09-30),
3. 6610694 - Condensed pyridazine compounds, their production and use (2003-08-26),
4. 6248740 - Condensed pyridazine derivatives, their production and use (2001-06-19),
5. 5491145 - Imidazopyridazines, their production and use (1996-02-13),
6. 5482939 - Triazolopyridazine compounds, their production and use (1996-01-09),
7. 5389633 - Triazolopyridazine compounds, their production and use (1995-02-14),
8. 5369104 - Pyridazine compounds, their production and use (1994-11-29),
9. 4851422 - Antibiotic (1989-07-25),
10. 4751299 - Optically active .beta.-lactams and method of their production (1988-06-14),
11. 4183859 - Thenoylindan derivatives (1980-01-15),
12. 4154731 - Spiro[cyclopropane-1,2'-indolin]-3'-ones (1979-05-15),
13. 4105670 - Spiro[cyclopropane-1,2'-indolin]-3'-ones (1978-08-08),
14. 3992370 - 1 (1976-11-16),

Title: The Innovative Contributions of Yasuhiko Kawano

Introduction

Yasuhiko Kawano is a prominent inventor based in Suita, Japan. He has made significant contributions to the field of pharmaceuticals, holding a total of 14 patents. His work focuses on developing compounds that address various inflammatory diseases and allergic conditions.

Latest Patents

Among his latest patents is a groundbreaking invention related to Furoisoquinoline derivatives. This compound exhibits an excellent phosphodiesterase (PDE) IV-inhibiting effect, making it a promising therapeutic agent for conditions such as bronchial asthma, chronic obstructive pulmonary disease (COPD), rheumatoid arthritis, autoimmune diseases, and diabetes. Another notable patent involves condensed pyridazine derivatives, which are useful in pharmaceutical compositions for preventing or treating allergic skin diseases, including contact dermatitis, pruritus, dried dermatitis, acute urticaria, and prurigo.

Career Highlights

Yasuhiko Kawano is currently associated with Takeda Chemical Industries, Inc., a leading pharmaceutical company. His innovative work has positioned him as a key figure in the development of new therapeutic agents that can significantly improve patient outcomes.

Collaborations

Throughout his career, Kawano has collaborated with esteemed colleagues, including Akio Miyake and Yasuko Ashida. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical solutions.

Conclusion

Yasuhiko Kawano's contributions to the field of pharmaceuticals through his innovative patents demonstrate his commitment to addressing critical health issues. His work continues to pave the way for advancements in therapeutic agents that can improve the quality of life for many individuals.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…